ArticleExperimental and clinical psychopharmacology2025
Is bedtime use of kratom (Mitragyna speciosa) a sleep aid or disruptor? Examining its daily effects and individual differences.
Chung Jung Mun, Patricia Timmons, Leigh V Panlilio, Christopher D Verrico, Ynhi T Thomas, C Austin Zamarripa, David H Epstein, Kirsten E Smith
Abstract read
In one paragraphArticle in Experimental and clinical psychopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Patricia TimmonsCollege of Health Solutions, Arizona State University.
Leigh V PanlilioReal-World Assessment, Prediction, and Treatment Unit, National Institute on Drug Abuse, Intramural Research Program.
Christopher D VerricoMenninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine.
Ynhi T ThomasMenninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine.
C Austin ZamarripaDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine.
David H EpsteinReal-World Assessment, Prediction, and Treatment Unit, National Institute on Drug Abuse, Intramural Research Program.
Kirsten E SmithDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine.
Funding
Sleep and circadian rhythm disturbances as risk and progression factors for multiple chronic pain conditionsR01NS129887 · NINDS · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI Chung Jung Mun · 2023 to 2026
$2.5MReal-world momentary assessment of kratom use and laboratory-based observed cessation accompanied by product assays: Toward an interdisciplinary characterization of kratom use and pharmacologyR00DA055571 · NIDA · JOHNS HOPKINS UNIVERSITY · PI SMITH, KIRSTEN · 2024 to 2025
$498kNational Institutes of Health; National Institute on Drug AbuseNIDA NIH HHS K99 DA055571NIDA NIH HHS R00 DA055571NINDS NIH HHS R01 NS129887
6 · The paper itselfAbstract
Indexed as
MitragynaPlant ExtractsSleepSleep Aids, PharmaceuticalAdultAgedChronic PainEcological Momentary AssessmentFemaleHumansIndividualityMaleMiddle AgedSex FactorsSleep QualityYoung AdultPlant ExtractsSleep Aids, Pharmaceutical
Identifiers
PMID40839514
PMCPMC12772645
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390